bimagrumab semaglutide combination trial plus confers weight loss while preserving lean mass bimagrumab semaglutide combination trial Beyond

Learn how this investigational triple receptor agonist affects bowel habits, what clinical trial data shows, and when to seek medical advice.

Combining semaglutide with alcohol requires careful planning

Oral semaglutide and the new Wegovy pill are making headlines, but are they more effective than injections

Download this stock image: 3D rendering of a GLP-1 agonist injector pen, a weight loss medication, with a medical measuring tape or ruler spiraling dynamically around its form

GLP-1 GOLD

Sciwind Biosciences has shared late-stage trial data for its injectable GLP-1 therapy, signaling Chinese firms intensifying bid to challenge incumbents like Eli Lilly (NYSE: LLY) and Novo Nordisk (NOV: N) in the global obesity drug market